OHI--Randomized Control Trial to Evaluate Efficacy, Acceptability, and Perception of Benefit of an Innovative Custom AFO
Sponsor: Bijan Najafi, PhD
A PHASE2 clinical study on Accidental Falls and Arthritis, this trial is completed. The trial is conducted by Bijan Najafi, PhD and has accumulated 11 data snapshots since 2016. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Jan 2023 — Jul 2024 [monthly]
Completed PHASE2
-
Dec 2022 — Jan 2023 [monthly]
Completed PHASE2
-
Jan 2021 — Dec 2022 [monthly]
Completed PHASE2
▶ Show 6 earlier versions
-
Mar 2020 — Jan 2021 [monthly]
Completed PHASE2
-
Feb 2019 — Mar 2020 [monthly]
Completed PHASE2
Status: Active Not Recruiting → Completed
-
Aug 2018 — Feb 2019 [monthly]
Active Not Recruiting PHASE2
Status: Recruiting → Active Not Recruiting
-
Jun 2018 — Aug 2018 [monthly]
Recruiting PHASE2
-
Aug 2017 — Jun 2018 [monthly]
Recruiting PHASE2
-
Jan 2017 — Aug 2017 [monthly]
Recruiting PHASE2
First recorded
May 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Bijan Najafi, PhD
- Orthotic Holdings, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .